| Dr Stacy Scott Cohen, DC | |
|
1536 Capitol Trl, Newark, DE 19711-5716 | |
| (302) 454-1200 | |
| (302) 454-1238 |
| Full Name | Dr Stacy Scott Cohen |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 40 Years |
| Location | 1536 Capitol Trl, Newark, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144231697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | DEF10000192 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Newark Chiropractic Health Center Pa | 3072415587 | 3 |
News Archive
About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
The sticky residue left behind by tobacco smoke can do worse damage than stinking up furniture and discoloring walls.
ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.
Rutgers researchers have identified a gene - and the molecular function of its protein product - that provides an important clue to further understanding obesity and may point the way to new drugs to control fat metabolism.
› Verified 9 days ago
| Provider Name | Newark Chiropractic Health Center Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649283995 PECOS PAC ID: 3072415587 Enrollment ID: O20040124000170 |
News Archive
About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
The sticky residue left behind by tobacco smoke can do worse damage than stinking up furniture and discoloring walls.
ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.
Rutgers researchers have identified a gene - and the molecular function of its protein product - that provides an important clue to further understanding obesity and may point the way to new drugs to control fat metabolism.
› Verified 9 days ago
| Provider Name | Midway Chiropractic, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821001181 PECOS PAC ID: 4789576539 Enrollment ID: O20040326000327 |
News Archive
About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
The sticky residue left behind by tobacco smoke can do worse damage than stinking up furniture and discoloring walls.
ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.
Rutgers researchers have identified a gene - and the molecular function of its protein product - that provides an important clue to further understanding obesity and may point the way to new drugs to control fat metabolism.
› Verified 9 days ago
| Provider Name | Lewes Chiropractic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508491481 PECOS PAC ID: 5496184657 Enrollment ID: O20200409000803 |
News Archive
About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
The sticky residue left behind by tobacco smoke can do worse damage than stinking up furniture and discoloring walls.
ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.
Rutgers researchers have identified a gene - and the molecular function of its protein product - that provides an important clue to further understanding obesity and may point the way to new drugs to control fat metabolism.
› Verified 9 days ago
| Provider Name | Westown Wellness Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1912597923 PECOS PAC ID: 6800203860 Enrollment ID: O20210318002906 |
News Archive
About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
The sticky residue left behind by tobacco smoke can do worse damage than stinking up furniture and discoloring walls.
ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.
Rutgers researchers have identified a gene - and the molecular function of its protein product - that provides an important clue to further understanding obesity and may point the way to new drugs to control fat metabolism.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stacy Scott Cohen, DC 1536 Capitol Trl, Newark, DE 19711-5716 Ph: (302) 454-1200 | Dr Stacy Scott Cohen, DC 1536 Capitol Trl, Newark, DE 19711-5716 Ph: (302) 454-1200 |
News Archive
About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
The sticky residue left behind by tobacco smoke can do worse damage than stinking up furniture and discoloring walls.
ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.
Rutgers researchers have identified a gene - and the molecular function of its protein product - that provides an important clue to further understanding obesity and may point the way to new drugs to control fat metabolism.
› Verified 9 days ago
Dr. Kristi Dillon, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 87b Omega Dr, Newark, DE 19713 Phone: 302-733-0980 Fax: 302-733-7495 | |
Gregory J Serge, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1101 Twin C Ln Ste 201, Newark, DE 19713 Phone: 302-892-9355 Fax: 302-892-3494 | |
Dr. Deana Marie Burd, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 300 Christiana Medical Ctr, Newark, DE 19702 Phone: 302-731-0869 Fax: 302-292-0669 | |
Spinal Specialists Of Delaware Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 300 Christiana Medical Ctr, Newark, DE 19702 Phone: 302-731-0869 Fax: 302-292-0669 | |
Renu Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 907 S College Ave, Newark, DE 19713 Phone: 302-368-0124 | |
Rehab And Wellness Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2600 Glasgow Ave Ste 120, Newark, DE 19702 Phone: 302-836-8200 | |
Dr. Marie Swasy, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 89 Omega Dr Ste 89, Newark, DE 19713 Phone: 302-332-3312 |